Cross Keys Capital served as the exclusive M&A advisor to The Retina Care Center, LLC ("RCC") in its affiliation with PRISM Vision Group™. The Retina Care Center is a single-specialty eye care center providing expert management and care for patients with eye problems specific to the retina and vitreous.
Led by Eric P. Suan, M.D., Matthew A. Speicher, M.D., Newman J. Sund, M.D., Ph.D., Timothy D. Polk, M.D., and Rohit R. Lakhanpal, M.D., F.A.C.S., The Retina Care Center has been committed to offering patients the most sophisticated and comprehensive diagnostic evaluations and the most current approved treatment for all vitreoretinal disorders since 1998. The team consists of 5 Board-certified, fellowship-trained ophthalmologists and covers 10 locations across Maryland, Pennsylvania, and Delaware.
“The Retina Care Center is renowned for the advanced level of care they provide to their patients,” said Steven A. Madreperla, MD, PhD, President and CEO, PRISM Vision Group. “This affiliation not only expands the offering of specialized retina care available through PRISM Vision Group affiliated practices geographically, but further serves our mission to support the provision of world-class, comprehensive eyecare, while building an unrivaled practice environment for our affiliated doctors and staff.”
In reflecting on the Cross Keys process that resulted in RCC’s affiliation with PRISM, Dr. Suan stated, "Cross Keys was exceptional in shepherding us [RCC] through this entire process. Leaving this type of process to a great professional team was our smartest move. Cross Keys’ wisdom, patience, coaching, and perseverance not only met but exceeded our expectations. There is no substitute for working with the best!"
Jeanne Proia, Managing Director at Cross Keys, commented, "The Retina Care Center has a long-standing reputation for providing the highest quality vitreoretinal eye care to the surrounding Baltimore-area community. We are grateful to have advised on their behalf in their partnership to another exceptional group in PRISM."